标题/作者	年份
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial TM Maher, VA Tudor, P Saunders, MA Gibbons, SV Fletcher, CP Denton, ... The Lancet Respiratory Medicine 11 (1), 45-54	2023
Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: a work group report of the AAAAI primary immunodeficiency and altered immune response committees IM Otani, HK Lehman, AM Jongco, LR Tsao, AE Azar, TK Tarrant, E Engel, ... Journal of Allergy and Clinical Immunology 149 (5), 1525-1560	2022
Systematic review and meta-analysis for 2017 clinical practice guidelines of the Japan research committee of the ministry of health, labour, and welfare for intractable vasculitis for the management of ANCA-associated vasculitis K Nagasaka, M Harigai, N Hagino, A Hara, T Horita, T Hayashi, M Itabashi, ... Modern rheumatology 29 (1), 119-129	2019
Hypereosinophilic syndromes: treatment F Roufosse, AD Klion, PF Weller, AM Feldweg UpToDate. Retrieved	2021
ANCA associated vasculitis subtypes: recent insights and future perspectives K Austin, S Janagan, M Wells, H Crawshaw, S McAdoo, JC Robson Journal of Inflammation Research, 2567-2582	2022
COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis ED Batu, S Sener, S Ozen Seminars in Arthritis and Rheumatism 55, 152047	2022
Long‐Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis PA Merkel, JL Niles, LE Mertz, PB Lehane, P Pordeli, F Erblang, N Allen, ... Arthritis Care & Research 73 (9), 1372-1378	2021
Obinutuzumab as treatment for ANCA-associated vasculitis NA Amudala, S Boukhlal, B Sheridan, CA Langford, A Geara, PA Merkel, ... Rheumatology 61 (9), 3814-3817	2022
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update B Hellmich, B Sanchez-Alamo, JH Schirmer, A Berti, D Blockmans, ... Annals of the Rheumatic Diseases	2023
Systemic vasculitis: one year in review 2022 G La Rocca, G Del Frate, P Delvino, F Di Cianni, M Moretti, N Italiano, ... Clin Exp Rheumatol 40 (4), 673-87	2022
Eosinophilic pneumonia V Cottin Orphan lung diseases: a clinical guide to rare lung disease, 277-309	2023
Novel targets for drug use in eosinophilic granulomatosis with polyangiitis M Uzzo, F Regola, B Trezzi, P Toniati, F Franceschini, RA Sinico Frontiers in Medicine 8, 754434	2021
Therapeutic advances in eosinophilic granulomatosis with polyangiitis JA Ford, Y Aleatany, O Gewurz-Singer Current opinion in rheumatology 34 (3), 158-164	2022
Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunities A Berti, F Atzeni, L Dagna, S Del Giacco, G Emmi, C Salvarani, A Vaglio Annals of the rheumatic diseases 82 (2), 164-168	2023
Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study M Ueno, I Miyagawa, T Aritomi, K Kimura, S Iwata, K Hanami, S Fukuyo, ... Arthritis research & therapy 24 (1), 1-9	2022
A review of anti-IL-5 therapies for eosinophilic granulomatosis with polyangiitis H Koike, R Nishi, S Yagi, S Furukawa, Y Fukami, M Iijima, M Katsuno Advances in therapy 40 (1), 25-40	2023
A personalized rituximab retreatment approach based on clinical and B-cell biomarkers in ANCA-associated vasculitis J Arnold, EM Vital, S Dass, A Aslam, AC Rawstron, S Savic, P Emery, ... Frontiers in Immunology 12, 803175	2022
Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis M Harigai, H Takada Modern Rheumatology 32 (3), 475-483	2022
Expert perspective: Management of antineutrophil cytoplasmic antibody–associated vasculitis NJ Patel, JH Stone Arthritis & Rheumatology 74 (8), 1305-1317	2022
The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculitis JY Pyo, SS Ahn, JJ Song, YB Park, SW Lee The Journal of rheumatology 50 (2), 213-218	2023

1 - 20

计算机程序会自动估算并确定日期和引用次数。